These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1171350)

  • 1. Adrenal function in the carcinoid syndrome: effects of the serotonin antagonist cyproheptadine.
    Plank J; Feldman JM
    Metabolism; 1975 Sep; 24(9):1035-46. PubMed ID: 1171350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of adrenal function by the anti-serotonin agent cyproheptadine.
    Plonk J; Feldman J
    J Clin Endocrinol Metab; 1976 Feb; 42(2):291-5. PubMed ID: 177441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose intolerance in the carcinoid syndrome.
    Feldman JM; Plonk JW; Bivens CH; Lebovitz HE
    Diabetes; 1975 Jul; 24(7):664-71. PubMed ID: 125668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin secretion in the carcinoid syndrome.
    Feldman JM; Plonk JW; Bivens CH; Lebovitz HE; Handwerger S
    Am J Med Sci; 1975; 269(3):333-47. PubMed ID: 125543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion.
    Brismar K; Werner S; Thorén M; Wetterberg L
    J Endocrinol Invest; 1985 Apr; 8(2):91-5. PubMed ID: 2993405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary free cortisol excretion in patients with hyperserotoninaemia from the carcinoid syndrome.
    Feldman JM
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):541-8. PubMed ID: 316372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
    Feldman JM
    Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
    Nelson JC; Tindall DJ
    Am J Med Sci; 1978; 275(2):165-72. PubMed ID: 208417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
    Feldman JM; Bivens CH; Skyler JS; Lebovitz HE
    Horm Metab Res; 1975 Jul; 7(4):279-83. PubMed ID: 1150128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
    van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
    Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose metyrapone test at 06.00 h: an accurate method for assessment of pituitary-adrenal reserve.
    Dickstein G; Lahav M; Orr ZS
    Acta Endocrinol (Copenh); 1986 May; 112(1):28-34. PubMed ID: 3716755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor.
    Malchoff CD; Orth DN; Abboud C; Carney JA; Pairolero PC; Carey RM
    Am J Med; 1988 Apr; 84(4):760-4. PubMed ID: 2840823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
    Spigset O; Kristoffersson A; Mjörndal T
    Scand J Clin Lab Invest; 2004; 64(1):3-8. PubMed ID: 15025423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cortisol and growth hormone in the counter-regulation of insulin-induced hypoglycemia.
    Feldman JM; Plonk JW; Bivens CH
    Horm Metab Res; 1975 Sep; 7(5):378-81. PubMed ID: 1183916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
    Kema IP; de Vries EG; Schellings AM; Postmus PE; Muskiet FA
    Clin Chem; 1992 Apr; 38(4):534-40. PubMed ID: 1373675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical testing of the hypothalamic-pituitary-adrenocortical system in states of hypo- and hypercortisolism.
    Gwinup G; Johnson B
    Metabolism; 1975 Jun; 24(6):777-91. PubMed ID: 165367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoid tumors--somatostatine in the diagnosis and therapy.
    Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J
    Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.
    Mao C; el Attar A; Domenico DR; Kim K; Howard JM
    Int J Pancreatol; 1998 Apr; 23(2):153-64. PubMed ID: 9629513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.